Praxis Precision Medicines, Inc. - Common Stock (NQ:PRAX)

282.25 +2.11 (+0.75%)

Delayed Quote Updated: 11:00 AM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Praxis Precision Medicines, Inc. - Common Stock

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Praxis Precision Medicines Announces Positive Topline Results from PRAX-628 Phase 1 Study Enabling Best-in-Class Profile

May 11, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Present at the American Academy of Neurology 2023 Annual Meeting

April 19, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Announces Upcoming Ulixacaltamide Presentations & Events

April 17, 2023

Ulixacaltamide essential tremor end-of-phase 2 meeting with FDA scheduled for June 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Outlines Upcoming Plans For Pediatric Epilepsy Programs ↗

September 07, 2022

Via Benzinga

Praxis Precision Medicines to Present at 22nd Annual Needham Virtual Healthcare Conference

April 06, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗

March 11, 2023

The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 6, 2023 ↗

March 06, 2023

Via Benzinga

Praxis Precision Medicines to Present at Upcoming Investor Conferences

March 03, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Dow Jumps Over 300 Points; S&P 500 Rises 1.5% ↗

March 03, 2023

U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Friday. The Dow traded up 1.03% to 33,343.73 while the NASDAQ rose 1.92% to 11,682.86. The S&P...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

March 03, 2023

Via Benzinga

Nasdaq Up 150 Points; Crude Oil Rises 1% ↗

March 03, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Friday. The Dow traded up 0.59% to 33,197.08 while the NASDAQ rose 1.32% to 11,614.60. The S&P...

Via Benzinga

Why Puma Biotechnology Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

March 03, 2023

Gainers ObsEva SA (NASDAQ: OBSV) surged 86.6% to $0.1978 after dropping over 12% on Thursday. ObsEva recently announced strategic reorganization to consolidate operations in Switzerland.

Via Benzinga

Dow Surges Over 100 Points; US Services PMI Rises In February ↗

March 03, 2023

U.S. stocks traded higher this morning, with the Dow Jones gaining more than 100 points on Friday. Following the market opening Friday, the Dow traded up 0.42% to 33,140.85 while the NASDAQ rose 1.02%...

Via Benzinga

Despite Trial Failure Praxis Still Seeks Advancing Essential Tremor Program Into Phase 3 Study ↗

March 03, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

March 03, 2023

Via Benzinga

Praxis Precision Medicines Announces Topline Results from the Essential1 Study of Ulixacaltamide for the Treatment of Essential Tremor and Continued Advancement of Program to Phase 3

March 03, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

February 07, 2023

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

January 17, 2023

We're starting off Tuesday with a look at the biggest pre-market stock movers that traders will want to keep an eye on today!

Via InvestorPlace

US Stocks Edge Lower; Bank of America Profit Tops Views ↗

January 13, 2023

U.S. stocks traded lower this morning, with the Dow Jones dropping around 50 points on Friday.

Via Benzinga

Praxis Precision Medicines and UCB Announce Epilepsy Research Collaboration

December 13, 2022

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Present at the American Epilepsy Society 2022 Annual Meeting

November 28, 2022

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Advance PRAX-562 Phase 2 Study in Pediatric Patients with Developmental and Epileptic Encephalopathies

November 28, 2022

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines Provides Corporate Update and Reports Third Quarter 2022 Financial Results

November 09, 2022

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Praxis Precision Medicines to Present at Upcoming Investor Conferences

November 07, 2022

From Praxis Precision Medicines, Inc.

Via GlobeNewswire

Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday ↗

October 17, 2022

Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.

Via Benzinga

Ambit Inc. to Present Novel Projection Methodology for Rare Developmental and Epileptic Encephalopathies (DEEs) at the 2022 Child Neurology Society Annual Meeting

October 11, 2022

Ambit to showcase its prevalence projection approach, co-developed with Praxis, for rare developmental and epileptic encephalopathies (DEEs) as a Platform Presentation at this year's annual Child...

Via Newswire.com

Needham Previews Neurocrine's Upcoming Mid-Stage Data from Essential Tremor Study ↗

July 11, 2022

Needham previews the upcoming Phase 2 data readout for Neurocrine Biosciences Inc's (NASDAQ: NBIX) NBI-827104, a t-type calcium channel blocker in essential tremor (ET), by mid-2022.

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

June 08, 2022

Wells Fargo cut Lowe's Companies, Inc. (NYSE: LOW) price target from $260 to $240. Lowe's shares fell 0.7% to $194.36 in pre-market trading.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For June 7, 2022 ↗

June 07, 2022

Upgrades

Via Benzinga

Tesla, Twitter And 76 Biggest Movers From Friday ↗

July 11, 2022

Gainers Seritage Growth Properties (NYSE: SRG) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board...

Via Benzinga

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.